newsfilter
← Latest News
GlobeNewswire·

Algernon Pharmaceuticals Reports Results of Study Showing 93% Cough Suppression with Ifenprodil

VANCOUVER, British Columbia, July 16, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE:AGN) (FRANKFURT: AGW) (OTCQB:AGNPF) (the "Company" or "Algernon") a clinical stage pharmaceutical development company,